Search results
10 Best ETFs To Buy and Hold for Long-Term Growth
GoBankingRates via AOL· 1 day agoIf you're a long-term investor looking to diversify your growth portfolio, there are a number of exchange-traded funds that can help you reach your...
Pharma Stock Roundup: LLY's CFO Departs, ABBV, AZN Drugs Get CHMP Approval
Zacks via Yahoo Finance· 6 days agoRecap of the Week’s Most Important Stories Lilly’s CFO Departs: Lilly’s executive vice president and...
Healthy Returns: Drugmakers release promising cancer drug data – and AstraZeneca wins big
CNBC· 6 days agoPatients with musculoskeletal conditions who like to stay in their pajamas received some welcome...
European Midday Briefing: Stocks, Euro Hit by European Political Upheaval
Morningstar· 3 days agoEuropean stocks fell on Monday after European elections resulted in strong gains for right-wing Euroskeptic parties, prompting Emmanuel Macron to call a snap election in France. The main takeaways ...
Chutes & Ladders—Sanofi research head Frank Nestle says au revoir
FierceBiotech· 6 days agoPlease send the good word—or the bad—from your shop to Gabrielle Masson and it will be featured here...
AbbVie's (ABBV) Ovarian Cancer Therapy Meets Study Goal
Zacks· 7 days agoData from a mid-stage study shows that treatment with AbbVie's (ABBV) Elahere achieves an objective response rate of almost 52% in certain heavily pre-treated patients with ovarian cancer.
BlackRock Favoring Growth Heading Into Second Half
ETF Trends via Yahoo Finance· 6 days agoThe BlackRock Target Allocation Team, which runs model portfolios followed by many advisors, turned even more bullish this week. Indeed, the current...
Can Chemo Benefit Older Patients With Pancreatic Cancer?
Medscape· 7 days agoBetter tools are needed to identify vulnerable older patients with metastatic pancreatic cancer who...
Tirzepatide Shows Improvements in MASH Resolution, Fibrosis
Medscape· 4 days agoEncouraging phase 2 results of tirzepatide in the resolution of MASH and improvement in fibrosis...
The U.S. is fighting high drug prices. Big Pharma isn't sweating — yet
Quartz· 3 days agoA key goal of the Biden administration has been to rein in healthcare costs. As the administration...